Research and development

Our ambitious programmes aim to substantially reduce global epidemic and pandemic risk. CEPI’s priority diseases include Chikungunya, COVID-19, Ebola, Lassa Fever, MERS, Mpox, Nipah, Rift Valley Fever, and novel viral threats with epidemic or pandemic potential (also known as “Disease X”).

A team of scientists working on vaccine creating in a modern laboratory

Biosecurity

CEPI’s inaugural Biosecurity Strategy—supported by funding from Global Affairs Canada—aims to bolster global health security, underscoring its commitment to tackling emerging epidemic and pandemic threats, whether they arise naturally, accidentally or through deliberate misuse.

Read more
scientist in lab coat holding a pipette and a glass vial

Call for Proposals

We invite innovators worldwide to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.

Apply now
University of Queensland scientists in a lab

Latest News

CEPI Securing the Future
News

CEPI launches global plan to secure the future against epidemic and pandemic threats

Biosecurity icon
Blog

Strengthening biosecurity and biosafety oversight: CEPI publishes its first Biosecurity Policy

Korea 100 Days Mission exercise
News

Korea runs landmark pandemic simulation exercise to strengthen outbreak readiness

National Assembly Roundtable
News

CEPI and Korea discuss future of AI-driven international health cooperation